Effect of ivabradine in patients with left-ventricular systolic dysfunction: a pooled analysis of individual patient data from the BEAUTIFUL and SHIFT trials

Effects on Outcomes of Heart Rate Reduction by Ivabradine in Patients With Congestive Heart Failure: Is There an Influence of Beta-Blocker Dose?

(2012) Karl Swedberg et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Heart rate: a forgotten link in coronary artery disease?

(2011) Kim M. Fox et al.   Nature Reviews Cardiology

Adherence to Guideline-Recommended Adjunctive Heart Failure Therapies Among Outpatient Cardiology Practices (Findings from IMPROVE HF)

(2010) Clyde W. Yancy et al.   AMERICAN JOURNAL OF CARDIOLOGY

Usefulness of Heart Rate at Rest as a Predictor of Mortality, Hospitalization for Heart Failure, Myocardial Infarction, and Stroke in Patients With Stable Coronary Heart Disease (Data from the Treating to New Targets [TNT] Trial)

(2010) Jennifer E. Ho et al.   AMERICAN JOURNAL OF CARDIOLOGY

EURObservationalResearch Programme: The Heart Failure Pilot Survey (ESC-HF Pilot)

(2010) Aldo P. Maggioni et al.   EUROPEAN JOURNAL OF HEART FAILURE

Vascular Pathophysiology in Response to Increased Heart Rate

(2010) Florian Custodis et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study

(2010) Karl Swedberg et al.   LANCET

Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial

(2010) Michael Böhm et al.   LANCET

Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects

(2010) W. Philip T. James et al.   NEW ENGLAND JOURNAL OF MEDICINE

Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial

(2008) Kim Fox et al.   LANCET

Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial

(2008) Kim Fox et al.   LANCET